+1,011.8%
MRNA vs ENB
+138.7%
+873.2%
-95.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | ENB | Excess | Alpha |
|---|---|---|---|---|
| 1D | -3.9% | -0.3% | -3.6% | -3.9% |
| 7D | -17.6% | +0.1% | -17.7% | -17.6% |
| 30D | -5.1% | -0.6% | -4.6% | -5.1% |
| 3M | +220.8% | -5.4% | +226.3% | +220.8% |
| 6M | +321.7% | -12.3% | +334.0% | +325.8% |
| YTD | +601.3% | +4.0% | +597.2% | +585.6% |
| 1Y | +735.2% | +4.2% | +731.0% | +716.0% |
| 3Y | +170.5% | +65.7% | +104.9% | +142.9% |
| 5Y | -14.6% | +58.4% | -73.0% | -22.0% |
| All | +1,011.8% | +138.7% | +873.2% | +857.2% |
Cumulative growth
Daily Returns
Daily percentage return beside ENB.
Daily Out/Under-Performance
Portfolio return minus ENB return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × ENB return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded ENB wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling